» Articles » PMID: 34497948

Risk Factors for Mortality and Readmission After Shoulder Hemiarthroplasty for Fracture

Overview
Publisher Sage Publications
Date 2021 Sep 9
PMID 34497948
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Limited information exists regarding mortality and readmission following proximal humerus fracture. This study examines risk factors following hemiarthroplasty for these fractures.

Methods: A retrospective analysis of prospectively collected data on 788 patients treated with hemiarthroplasty for acute proximal humerus fracture from January 2005 to December 2011 was conducted. One-year mortality and 30- and 90-day hospital readmission were evaluated. Patient risk factors included age, race, gender, diabetes, American Society of Anesthesiologists (ASA) score, and body mass index.

Results: One-year mortality rate was 5.2%. Patients with ASA ≥3 had 2.37 times (95% confidence interval [CI]: 1.05-5.32) greater mortality risk versus patients with ASA1/2. The 30-day readmission rate was 8.4% and at 90 days was 12.6%. Females had 0.53 risk of readmission versus males (95% CI: 0.29-0.96). Patients with ASA ≥3 had 1.79 (95% CI: 1.04-3.09) risk of 90-day readmission versus patients with ASA1/2; females had 0.52 (95% CI: 0.31-0.85) risk of readmission versus males. Increased age increased all odds ratios.

Conclusions: Readmission rate after hemiarthroplasty for proximal humerus fracture is significant both at 30 and 90 days and is higher in males. Age and ASA ≥3 correlate with this. Diabetes and obesity were not significant risk factors for readmission or mortality.

Citing Articles

Readmission, reoperation, and nonhome discharge rates in patients receiving surgical treatment for proximal humerus fractures.

Ling K, Kashanchi K, VanHelmond T, Nazemi A, Kim M, Komatsu D JSES Int. 2022; 6(4):573-580.

PMID: 35813141 PMC: 9264000. DOI: 10.1016/j.jseint.2022.02.008.

References
1.
Spross C, Platz A, Erschbamer M, Lattmann T, Dietrich M . Surgical treatment of Neer Group VI proximal humeral fractures: retrospective comparison of PHILOS® and hemiarthroplasty. Clin Orthop Relat Res. 2011; 470(7):2035-42. PMC: 3369075. DOI: 10.1007/s11999-011-2207-1. View

2.
Keene G, Parker M, Pryor G . Mortality and morbidity after hip fractures. BMJ. 1993; 307(6914):1248-50. PMC: 1679389. DOI: 10.1136/bmj.307.6914.1248. View

3.
Boons H, Goosen J, van Grinsven S, van Susante J, van Loon C . Hemiarthroplasty for humeral four-part fractures for patients 65 years and older: a randomized controlled trial. Clin Orthop Relat Res. 2012; 470(12):3483-91. PMC: 3492647. DOI: 10.1007/s11999-012-2531-0. View

4.
Taylor F, Wright M, Zhu M . Hemiarthroplasty of the hip with and without cement: a randomized clinical trial. J Bone Joint Surg Am. 2012; 94(7):577-83. DOI: 10.2106/JBJS.K.00006. View

5.
Center J, Nguyen T, Schneider D, Sambrook P, Eisman J . Mortality after all major types of osteoporotic fracture in men and women: an observational study. Lancet. 1999; 353(9156):878-82. DOI: 10.1016/S0140-6736(98)09075-8. View